Evaluation of Limited Sampling Strategies for Mycophenolic Acid After Mycophenolate Mofetil Intake in Adult Kidney Transplant Recipients

被引:26
|
作者
Barraclough, Katherine A. [1 ]
Isbel, Nicole M. [1 ]
Franklin, Michael E. [2 ]
Lee, Katie J. [3 ]
Taylor, Paul J. [2 ]
Campbell, Scott B. [1 ]
Petchey, William G. [1 ]
Staatz, Christine E. [3 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld 4102, Australia
[2] Princess Alexandra Hosp, Dept Pharmacol, Brisbane, Qld 4102, Australia
[3] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia
基金
英国医学研究理事会;
关键词
limited sampling strategies; mycophenolate; cyclosporine; tacrolimus; kidney transplantation; UNDER-THE-CURVE; PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP; BAYESIAN-ESTIMATION; CLINICAL PHARMACOKINETICS; GLUCURONIDE METABOLITE; RENAL-TRANSPLANTATION; ACUTE REJECTION; AREA; CYCLOSPORINE; TACROLIMUS;
D O I
10.1097/FTD.0b013e3181fc8fbb
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Multiple limited sampling strategies (LSSs) have been proposed for estimation of mycophenolic acid (MPA) area under the concentration-time curve from 0 to 12 hours postdose (AUC(0-12)) after mycophenolate mofetil intake. The aim of this study was to provide summary information on all published LSSs for MPA and to evaluate their predictive performance in an independent population of kidney transplant recipients. Seventy-eight LSSs for MPA were identified. Sixty-nine full AUC profiles were collected from 45 subjects (25 cotreated with cyclosporine and 20 with tacrolimus). Predicted MPA AUC(0-12), calculated by applying the relevant concentration measurements within the LSS equations, was compared with full AUC calculated by using all concentration measurements in the linear trapezoidal rule. Four error indices (median prediction error, median percentage prediction error [MPPE], root median squared prediction error, and median absolute percentage prediction error [MAPE]) were used to evaluate bias and imprecision. Twelve of the 25 LSSs for cyclosporine-cotreated recipients and one of the 53 LSSs for tacrolimus-cotreated recipients displayed acceptable (less than 15%) bias and imprecision. In the cyclosporine group, two equations demonstrated the highest predictive power, one that used four time points in the first 6 hours postdose (r(2) = 0.84, MPPE 1.6%, MAPE 7.8%) and one that used four time points in the first 4 hours postdose (r(2) = 0.76, MPPE -0.8%, MAPE 10.2%). In the tacrolimus group, an equation that used two time points in the first 4 hours postdose was superior (r(2) = 0.80, MPPE -3.0%, MAPE 13.6%). Application of the LSSs most appropriate for cyclosporine-cotreated patients to the tacrolimus-cotreated group resulted in clinically unacceptable bias and imprecision and vice versa. High variability in performance of LSSs highlights the importance of validating any LSS before applying it to an alternative population. Attention to comedication use is of particular relevance when choosing a LSS.
引用
收藏
页码:723 / 733
页数:11
相关论文
共 50 条
  • [11] Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients
    Labriffe, Marc
    Micallef, Ludovic
    Woillard, Jean-Baptiste
    Monchaud, Caroline
    Saint-Marcoux, Franck
    Debord, Jean
    Marquet, Pierre
    THERAPEUTIC DRUG MONITORING, 2023, 45 (05) : 591 - 598
  • [12] Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil
    Li, H.
    Mager, D. E.
    Sandmaier, B. M.
    Maloney, D. G.
    Bemer, M. J.
    McCune, J. S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (04) : 393 - 402
  • [13] Limited Sampling Strategies for Predicting Area Under the Concentration-Time Curve of Mycophenolic Acid in Islet Transplant Recipients
    Al-Khatib, Mai
    Shapiro, R. Jean
    Partovi, Nilufar
    Ting, Lillian S. L.
    Levine, Marc
    Ensom, Mary H. H.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (01) : 19 - 27
  • [14] Mycophenolic Acid Exposure in High- and Low-Weight Renal Transplant Patients After Dosing With Mycophenolate Mofetil in the Opticept Trial
    Kaplan, Bruce
    Gaston, Robert S.
    Meier-Kriesche, Herwig-Ulf
    Bloom, Roy D.
    Shaw, Leslie M.
    THERAPEUTIC DRUG MONITORING, 2010, 32 (02) : 224 - 227
  • [15] Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients
    Barraclough, Katherine A.
    Isbel, Nicole M.
    McWhinney, Brett C.
    Ungerer, Jacobus P. J.
    Medley, Gregory
    Johnson, David W.
    Hawley, Carmel M.
    Leary, Diana R.
    Campbell, Scott B.
    Staatz, Christine E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (12) : 1243 - 1252
  • [16] Development and Validation of Limited Sampling Strategies for Tacrolimus and Mycophenolate in Steroid-Free Renal Transplant Regimens
    Poulin, Eric
    Greanya, Erica D.
    Partovi, Nilufar
    Shapiro, R. Jean
    Al-Khatib, Mai
    Ensom, Mary H. H.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (01) : 50 - 55
  • [17] Early Steroid Withdrawal and Optimization of Mycophenolic Acid Exposure in Kidney Transplant Recipients Receiving Mycophenolate Mofetil
    Le Meur, Yannick
    Thierry, Antoine
    Glowacki, Francois
    Rerolle, Jean-Philippe
    Garrigue, Valerie
    Ouali, Nacera
    Heng, Anne-Elisabeth
    Delahousse, Michel
    Albano, Laeticia
    Lang, Philippe
    Couzi, Lionel
    Jaureguy, Maite
    Lebranchu, Yvon
    Mousson, Christiane
    Glotz, Denis
    Kessler, Michele
    Vrtovsnik, Francois
    Rouanet, Stephanie
    Tagieva, Nailya
    Kamar, Nassim
    TRANSPLANTATION, 2011, 92 (11) : 1244 - 1251
  • [18] Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies
    Wang, Xipei
    Wu, Yijin
    Huang, Jinsong
    Shan, Songgui
    Mai, Mingjie
    Zhu, Jiade
    Yang, Min
    Shang, Dewei
    Wu, Zheng
    Lan, Jinhua
    Zhong, Shilong
    Wu, Min
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [19] No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration-Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus
    Endo, Takahito
    Ishimura, Takeshi
    Nishioka, Shun
    Yokoyama, Naoki
    Ogawa, Satoshi
    Fujisawa, Masato
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 286 - 292
  • [20] Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients
    Kuypers, Dirk R.
    Ekberg, Henrik
    Grinyo, Josep
    Nashan, Bjoern
    Vincenti, Flavio
    Snell, Paul
    Mamelok, Richard D.
    Bouw, Rene M.
    CLINICAL PHARMACOKINETICS, 2009, 48 (05) : 329 - 341